Wasim Malik

Wasim Q Malik was the founder of Altimate Health Corp., founded in 2020, and held the title of Director.
Current jobs include Director of Biomarker Research & Department at Mass General Brigham, Inc. since 2008; Board of Director at BioTrak Health, Inc.; Advisory Board Member at Honeywell International, Inc. since 2022; Independent Board Member at Nordovo Biosciences AS since 2022; Managing Partner at Iaso Ventures Management Firm LLC since 2020; Advisor at Celéri Health, Inc. since 2022; Board Member at Scaffold Therapeutics, Inc. since 2022; Board Member at Epilepsy Therapy Project since 2019; Advisor at Zafrens, Inc. since 2023; and Senior Advisor at The Broad Institute, Inc. since 2023.
Former jobs include Senior Advisor & Life Sciences at Health Catalyst, Inc. from 2019 to 2022; Advisor at Myolex, Inc. from 2018 to 2020; Independent Board Member at Saphetor SA from 2019 to 2020; Board Member at monARC Bionetworks, Inc. from 2018 to 2019; and Advisor at Pragma Biosciences, Inc. in 2021.
Education includes a doctorate from the University of Oxford, conferred in 2005.